News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sell-Off On This Drugmaker Is 'Overblown'—But Will It Keep Going?



9/7/2017 6:00:52 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
The sell-off Tuesday on Mallinckrodt (MNK) stock was overdone, analysts said Wednesday after a judge tossed out a slew of patients protecting a respiratory treatment.

Mallinckrodt lost 12.3% on Tuesday, diving to a three-week low. The stock fell as much as 2.4% on the stock market today before closing up 0.4% to 36.28. Shares of drugmakers also advanced 0.5%.



comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES